AACR Virtual Patient Advocate Forum
The Very Early Detection of Cancer signals
October 11, 2022
Late-stage diagnosis is a major contributor to cancer-related mortality, as patients diagnosed with advanced cancers have fewer treatment options and a greater likelihood of death. Early detection of cancer may, therefore, help reduce cancer-related mortality around the world. Screening programs for breast, colorectal, and cervical cancers have demonstrated the power of early cancer detection. Despite these successes, easy screening methods are currently unavailable for some of the world’s deadliest cancers and there is substantial debate on the potential of screening tests to identify early “signals” for multiple cancers to cause unintended harm. This Patient Advocate Forum highlights the latest research in cancer’s very early detection, as well as discusses the benefits and potential negatives of these new cancer screening tests.
Anna D. Barker, PhD, FAACR, Ellison Institute for Transformative Medicine
Timothy R. Rebbeck, PhD, Dana Farber Cancer Institute
Anjee Q. Davis, MPPA, Fight Colorectal Cancer
Philip E. Castle, PhD, MPH, National Cancer Institute
C. Jimmy Lin, MD, PhD, MHS, Freenome
Ruth B. Etzioni, PhD, Fred Hutchinson Cancer Research CenterPROGRAM AGENDA SPEAKER BIOS
AACR Patient Advocate Forums
The AACR is committed to providing educational programming to patients with cancer and patient advocacy communities to support their collective mission to find cures for all cancers. AACR Patient Advocate Forums invite leaders from patient advocacy, academia, industry, and healthcare communities to discuss pressing topics and the latest discoveries in cancer research. These virtual forums are provided quarterly at no cost to attendees and open to the public.